Abbott Diabetes Care, Inc.
Abbott Diabetes Care, Inc., a prominent player in the diabetes management industry, is headquartered in the United States. Founded in 1888, the company has evolved significantly, establishing itself as a leader in innovative diabetes care solutions. Abbott is renowned for its cutting-edge products, including the FreeStyle Libre continuous glucose monitoring system, which offers users real-time glucose data with unparalleled convenience. With a strong presence in North America, Europe, and Asia, Abbott Diabetes Care focuses on developing advanced technologies that empower individuals to manage their diabetes effectively. The company’s commitment to research and development has led to numerous milestones, solidifying its market position as a trusted provider of diabetes management tools. Abbott's unique approach combines user-friendly design with reliable performance, making it a preferred choice for patients and healthcare professionals alike.
DitchCarbon Score
How does Abbott Diabetes Care, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abbott Diabetes Care, Inc.'s score of 54 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abbott Diabetes Care, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Abbott Laboratories, any emissions data or climate commitments would be inherited from its parent company. Abbott Laboratories has made significant strides in addressing climate change, including setting science-based targets for emissions reductions. However, specific reduction targets or achievements for Abbott Diabetes Care, Inc. are not detailed in the available information. The company is part of a broader commitment to sustainability and climate action, aligning with initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Abbott Laboratories. While no absolute emissions figures are provided, Abbott Diabetes Care, Inc. is expected to adhere to the climate commitments and reduction strategies established by its parent company, reflecting a commitment to reducing its carbon footprint and contributing to global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abbott Diabetes Care, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
